Professional Documents
Culture Documents
www.kjoonline.org
Govt. Medical College, INTRODUCTION led to high mortality rates and vast expenses
Thrissur, Kerala, India
MRSA (Methicillin Resistant Staphylococcus caused by prolonged hospitalisation and usage
aureus) has been a pathogen linked to health care of additional antibiotics.
facilities and is a major cause of health care
1
Associate Professor of associated infections. More recently, CA-MRSA Community acquired MRSA strains
Pharmacology (Community acquired MRSA) strains have been emerged in late 1990 to 2000, infecting healthy
found to cause infection in patients with no risk people who had not been in contact with health
factors for HA-MRSA (Hospital associated care facilities. CA-MRSA differs from HA-MRSA
MRSA). The Center for Disease Control and in its genetic make-up, increased pathogenicity
prevention(CDC) reports that about one and susceptibility to antibiotic treatment.
percentage of the general public is infected with
this superbug. Community acquired MRSA is more easily
treated and is more virulent than Hospital acquired
Although 50-60 % of patients with MRSA MRSA. The genetic mechanism for the enhanced
are merely colonised, serious infections such as virulence in CA-MRSA remains an active area of
Correspondence should
those involving the blood stream, respiratory tract research. Panton-Valentine leukocidin (PVL)
be sent to: and bone or joints do occur. As per the guidelines genes are especially of interest because they are an
mbsuja@gmail.com released by the Infectious diseases society of unique feature of CA-MRSA.
America(IDSA) for treatment of MRSA, it is the
predominant cause of skin infections among The resistance of MRSA to beta-lactam
patients presenting to the emergency room. antibiotics is due to the presence of the mecA gene
sequence. The mecA gene produces trans peptidase
These infections are more difficult to treat PBP2a (penicillin-binding protein) that decreases
than infections caused by methicillin susceptible the bacterial affinity of the beta-lactam antibiotics.
isolates and MRSA spread easily among patients The mecA gene is a subset of a larger SCCmec gene
in hospitals. The toxicity of these pathogens and (Staphylococcal Cassette Chromosome mec gene),
limited effectiveness of available treatment have the genetic element that carries the mecA gene
encoding methicillin resistance.
Available online at
www.kjoonline.org
Several variations of the SCCmec gene have
Quick response code been sequenced. SCCmec gene types I, II and III
are found in HA-MRSA, whereas CA-MRSA
bacteria have the SCCmec type IV gene. This
difference may explain the continued susceptibility
of CA-MRSA compared with HA-MRSA to some
oral antibiotics such as trimethoprim-
sulfamethoxazole etc.
Figure 2. Diagram depicting antibiotic resistance through alteration of the antibiotics target site
spectrum of antimicrobial susceptibility, including Sulfa drugs Ceftaroline and Tigecycline are used to treat more severe
(like Co-trimoxazole), Tetracyclines (like Doxycycline and infections that do not respond to Glycopeptides such as
Minocycline) and Clindamycin (for osteomyelitis), Vancomycin Vancomycin. Current guidelines recommend Daptomycin for
is the drug of choice for treating CA-MRSA, according to a VISA bloodstream infections and endocarditis.
Henry Ford Hospital Study. HA-MRSA is resistant even to
these antibiotics and often is susceptible only to Vancomycin. Linezolid: A synthetic antimicrobial agent of
Oxazolidinone class and is effective against gram positive
Newer drugs, such as Linezolid and Daptomycin, are organisms. By binding to the 23S fraction of the 50S ribosomal
effective against both CA-MRSA and HA-MRSA. Ceftaroline subunit, it inhibits bacterial protein synthesis. Resistance is
and Ceftobiprole, new fifth generation cephalosporins, are the due to the modification of the ribosomal binding site and has
first beta-lactam antibiotics approved in the US to treat MRSA been reported clinically among enterococci and MRSA strains.
infections (skin and soft tissue only). It has good oral bioavailability.
Vancomycin and Teicoplanin: These are Glycopeptide It is generally well tolerated with only minor side effects.
antibiotics used to treat MRSA infections. Teicoplanin is a Thrombocytopenia has been reported and is related to
structural congener of Vancomycin that has a similar activity duration of therapy. So platelet should be monitored in
spectrum but a longer half-life. Because the oral absorption of patients with risk of bleeding. Linezolid is a weak monoamine
Vancomycin and Teicoplanin are very low, these agents must oxidase inhibitor. Patient receiving concomitant therapy with
be administered intravenously to control systemic infections. an adrenergic or serotonergic agent may experience an
enhancement of drug effects. It should be reserved as an
Treatment of MRSA infection with Vancomycin can be agent of last resort for treatment of infections caused by
complicated due to its ototoxicity and nephrotoxicity. Moreover, multiple drug resistant strains. Indiscriminate use and overuse
many clinicians believe that the efficacy of Vancomycin against will hasten selection of resistant strains and the eventual loss
MRSA is inferior to that of anti-staphylococcal beta-lactam of this valuable new agent.
antibiotics against methicillin-susceptible Staphylococcus aureus
(MSSA). Daptomycin: A cyclic lipopeptide antibiotic was recently
re visited because of the growing difficulty in treating resistant
Several newly discovered strains of MRSA show antibiotic gram positive organisms especially Vancomycin resistant gram
resistance even to Vancomycin and Teicoplanin. These new positive strains. Daptomycin, by binding to the cytoplasmic
evolutions of the MRSA bacterium have been dubbed membrane causes cell death. It has a concentration dependent
Vancomycin intermediate-sensitive Staphylococcus aureus bactericidal activity. Due to its unique mechanism of action it
(VISA). Linezolid, Quinupristin/Dalfopristin, Daptomycin, does not produce any cross resistance. There are no known
82 Kerala Journal of Orthopaedics Volume 27 | Issue 1 | January 2014
Invited Article
Sujatha: Drug treatment of MRSA infections
Route of
Antibiotics Drug Class Major side effects
Administration
Red man syndrome
Vancomycin Glycopeptide IV Ototoxicity,Nephrotoxicity
Ototoxicity,Granulocytopenia
Teicoplanin Glycopeptide IV / IM
GI Discomfort,Myelosuppression
Linezolid Oxazolidinone Oral / IV
GI side
Tigecycline Glycylcycline IV effects,Photosensitivity,Superinfection
Ceftaroline,Ceftobiprole Cephalosporins IV
Nephrotoxicity
Telavancin Lipoglycopeptide IV
Doxy- Phototoxicity,Mino-Vestibular
Doxy / Minocycline Tetracyclines Oral toxicity
Mupirocin Topical
Table 1. An overview of drugs used in MRSA infections
Kerala Journal of Orthopaedics Volume 27 | Issue 1 | January 2014 83
Invited Article
Sujatha: Drug treatment of MRSA infections
and skin structure infections and intra-abdominal infections. Daptomycin is a promising option for patients with bone and
joint infections such as MRSA osteomyelitis.
Telavancin: This is a lipoglycopeptide antibacterial agent
exhibits potent activity against MRSA isolates with reduced Costs of Linezolid therapy are higher than that of
susceptibility to Vancomycin. The plasma half-life is 8 hrs, which Vancomycin, but Linezolid brings into practice many advantages
supports once daily intravenous dosing. compensating this economical aspect. Availability of oral dosage
forms with reliable bioavailability creates the possibility of
Ceftaroline & Ceftobiprole: These new fifth generation ambulatory treatment and increases the patient compliance.
Cephalosporins are the first beta lactam antibiotics to be This will shorten the hospital stay thus reducing final treatment
effective against MRSA. Both have increased binding to costs.
Penicillin binding protein 2a, which mediates methicillin
resistance in staphylococci, resulting in bactericidal activity CONCLUSION
against these strains. Despite the emergence of resistant and multidrug-
resistant S. aureus, we have certain effective drugs in clinical use
Mupirocin: Perioperative prophylaxis with nasal for which little resistance has been observed: Vancomycin,
Mupirocin can reduce the incidence of MRSA skin and soft Quinupristin, Dalfopristin, Linezolid, Tigecycline, Telavancin,
tissue infections after orthopaedic surgery, probably by reducing Ceftaroline and Daptomycin. However, Vancomycin is less
nasal MRSA carriage in the endemic setting, without selecting effective for infections with MRSA isolates that have a higher
for Mupirocn resistance. MIC within the susceptible range.
Announcement
Kindly intimate the details, quoting your KOA membership number, current mailing address, email id and
contact number to one of the following addresses :-